22,135,656
Vote Records
28,570
Companies
12,092
Funds
3,981
Managers

Home › Companies › OCUGEN INC. › 2024-2025

OCUGEN INC. 2024-2025 Proxy Voting Records

At OCUGEN INC.'s shareholder meeting held June 5, 2025, in the 2024-2025 proxy season, 97 asset managers reported how they voted in their SEC Form N-PX filings, covering 514 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF OCUGEN, INC.'S NAMED EXECUTIVE OFFICERS. — OCUGEN INC.'s filing reports the proposal as approved, with 82% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: OCUGEN INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 5, 2025.

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and OCUGEN INC.’s Form 8-K, filed June 5, 2025 (Item 5.07 on EDGAR). Page generated November 8, 2026.

  • 8Reported items
  • 97Asset managers
  • 514Fund votes
  • June 5, 2025Meeting date

Results at a glance

Meeting of June 5, 2025: 5 items on OCUGEN INC.’s Form 8-K, filed June 5, 2025: 1 approved · 4 without a stated outcome.

Material dissent

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore OCUGEN INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by OCUGEN INC.

These tallies are OCUGEN INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 5, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

OCUGEN INC. — official shareholder meeting results, meeting held June 5, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Uday B. Kompella, Ph.D. 30,446,126---- 10,433,64064,407,267 74%Not verified—
Elect Director: Blaise Coleman 39,187,023---- 1,692,74364,407,267 96%Not verified—
Elect Director: Satish Chandran, Ph.D. 39,040,889---- 1,838,87764,407,267 96%Not verified—
2. Ratification of Independent Registered Public Accountant 101,459,2993,030,767796,967 ---- 97%Not verified—
3. Approval, on an advisory basis, of the compensation of the Company's named executive officers 31,296,2066,759,8012,832,759 --64,407,267 82%Approved—

Source: OCUGEN INC., Form 8-K, filed with the SEC on June 5, 2025 — read the filing on EDGAR.

How asset managers voted at the OCUGEN INC. 2024-2025 meeting

Each item below shows how the 97 asset managers that disclosed a OCUGEN INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of OCUGEN INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. The election of (i) Uday Kompella, Ph.D. and Blaise Coleman as Class II Directors to hold office until…: Blaise Coleman

No official matchDIRECTOR ELECTIONS

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 22 asset managers

Description as filed by funds: The election of (i) Uday Kompella, Ph.D. and Blaise Coleman as Class II Directors to hold office until the 2028 Annual Meeting and (ii) Satish Chandran, Ph.D. as a Class III Director to hold office until the 2026 Annual Meeting: Blaise Coleman

The 22 asset managers below reported 2,430,500 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 2,430,500
Largest asset managers voting on “The election of (i) Uday Kompella, Ph.D. and Blaise Coleman as Class II Directors to hold office until the 202” at OCUGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard1,128,7720 00For
Lincoln Financial219,4000 00For
Equitable211,8420 00For
Goldman Sachs187,1860 00For
AIG/SunAmerica147,7870 00For
Northern Trust120,3040 00For
Pacific Life90,4620 00For
Voya78,6040 00For
Fidelity73,4520 00For
Columbia Threadneedle37,7020 00For
Calvert25,0680 00For
Brighthouse22,7650 00For
TIAA22,2710 00For
ProShares15,4960 00For
State Street14,8690 00For
Brinker Capital Destinations Trust10,4170 00For
Nationwide9,7720 00For
PENN SERIES FUNDS INC9,1000 00For
Guggenheim4,5360 00For
Victory Capital3820 00For
T. Rowe Price2390 00For
DWS740 00For

2. The election of (i) Uday Kompella, Ph.D. and Blaise Coleman as Class II Directors to hold…: Satish Chandran, Ph.D.

No official matchDIRECTOR ELECTIONS

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 22 asset managers

Description as filed by funds: The election of (i) Uday Kompella, Ph.D. and Blaise Coleman as Class II Directors to hold office until the 2028 Annual Meeting and (ii) Satish Chandran, Ph.D. as a Class III Director to hold office until the 2026 Annual Meeting: Satish Chandran, Ph.D.

The 22 asset managers below reported 2,430,500 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 2,430,500
Largest asset managers voting on “The election of (i) Uday Kompella, Ph.D. and Blaise Coleman as Class II Directors to hold office until the 202” at OCUGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard1,128,7720 00For
Lincoln Financial219,4000 00For
Equitable211,8420 00For
Goldman Sachs187,1860 00For
AIG/SunAmerica147,7870 00For
Northern Trust120,3040 00For
Pacific Life90,4620 00For
Voya78,6040 00For
Fidelity73,4520 00For
Columbia Threadneedle37,7020 00For
Calvert25,0680 00For
Brighthouse22,7650 00For
TIAA22,2710 00For
ProShares15,4960 00For
State Street14,8690 00For
Brinker Capital Destinations Trust10,4170 00For
Nationwide9,7720 00For
PENN SERIES FUNDS INC9,1000 00For
Guggenheim4,5360 00For
Victory Capital3820 00For
T. Rowe Price2390 00For
DWS740 00For

3. The election of (i) Uday Kompella, Ph.D. and Blaise Coleman as Class II Directors to hold office…: Uday Kompella, Ph.D.

No official matchDIRECTOR ELECTIONS

49.5% of fund votes cast · no official result

FORWITHHOLD
Details: description as filed, votes by 22 asset managers

Description as filed by funds: The election of (i) Uday Kompella, Ph.D. and Blaise Coleman as Class II Directors to hold office until the 2028 Annual Meeting and (ii) Satish Chandran, Ph.D. as a Class III Director to hold office until the 2026 Annual Meeting: Uday Kompella, Ph.D.

The 22 asset managers below reported 1,202,463 for, 1,228,037 withheld. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 1,202,463WITHHOLD: 1,228,037
Largest asset managers voting on “The election of (i) Uday Kompella, Ph.D. and Blaise Coleman as Class II Directors to hold office until the 202” at OCUGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard1,128,7720 00For
Lincoln Financial00 0219,400Withhold
Equitable00 0211,842Withhold
Goldman Sachs00 0187,186Withhold
AIG/SunAmerica00 0147,787Withhold
Northern Trust00 0120,304Withhold
Pacific Life00 090,462Withhold
Voya00 078,604Withhold
Fidelity73,4520 00For
Columbia Threadneedle00 037,702Withhold
Calvert00 025,068Withhold
Brighthouse00 022,765Withhold
TIAA00 022,271Withhold
ProShares00 015,496Withhold
State Street00 014,869Withhold
Brinker Capital Destinations Trust00 010,417Withhold
Nationwide00 09,772Withhold
PENN SERIES FUNDS INC00 09,100Withhold
Guggenheim00 04,536Withhold
Victory Capital00 0382Withhold
T. Rowe Price2390 00For
DWS00 074Withhold

4. Elect Director: Blaise Coleman

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 39,187,023WITHHELD: 1,692,743
Details: description as filed, official tally, votes by 8 asset managers

Description as filed by funds: DIRECTOR: Blaise Coleman

OCUGEN INC.’s own tally for this item (“Elect Director: Blaise Coleman”): 39,187,023 for, 1,692,743 withheld, per its Form 8-K filed June 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 8 asset managers below reported 1,533,216 for.

FOR
FOR: 1,533,216
Largest asset managers voting on “DIRECTOR: Blaise Coleman” at OCUGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Charles Schwab860,2440 00For
BlackRock345,8500 00For
Global X165,1460 00For
Bridge Builder Trust55,6850 00For
John Hancock53,5660 00For
SEI42,1000 00For
Nationwide8,4630 00For
QUANTITATIVE MASTER SERIES LLC2,1620 00For

5. Elect Director: Satish Chandran, Ph.D.

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 39,040,889WITHHELD: 1,838,877
Details: description as filed, official tally, votes by 8 asset managers

Description as filed by funds: DIRECTOR: Satish Chandran, Ph.D.

OCUGEN INC.’s own tally for this item (“Elect Director: Satish Chandran, Ph.D.”): 39,040,889 for, 1,838,877 withheld, per its Form 8-K filed June 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 8 asset managers below reported 1,533,216 for.

FOR
FOR: 1,533,216
Largest asset managers voting on “DIRECTOR: Satish Chandran, Ph.D.” at OCUGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Charles Schwab860,2440 00For
BlackRock345,8500 00For
Global X165,1460 00For
Bridge Builder Trust55,6850 00For
John Hancock53,5660 00For
SEI42,1000 00For
Nationwide8,4630 00For
QUANTITATIVE MASTER SERIES LLC2,1620 00For

6. Elect Director: Uday B. Kompella, Ph.D.

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

74% Majority: yes · of votes cast

FOR 74%WITHHELD
FOR: 30,446,126WITHHELD: 10,433,640
Details: description as filed, official tally, votes by 8 asset managers

Description as filed by funds: DIRECTOR: Uday Kompella, Ph.D.

OCUGEN INC.’s own tally for this item (“Elect Director: Uday B. Kompella, Ph.D.”): 30,446,126 for, 10,433,640 withheld, per its Form 8-K filed June 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 74% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 8 asset managers below reported 1,075,953 for, 457,263 abstained.

FORABSTAIN
FOR: 1,075,953ABSTAIN: 457,263
Largest asset managers voting on “DIRECTOR: Uday Kompella, Ph.D.” at OCUGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Charles Schwab860,2440 00For
BlackRock00 345,8500Abstain
Global X165,1460 00For
Bridge Builder Trust00 55,6850Abstain
John Hancock00 53,5660Abstain
SEI42,1000 00For
Nationwide8,4630 00For
QUANTITATIVE MASTER SERIES LLC00 2,1620Abstain

7. Approval, on an advisory basis, of the compensation of the Company's named executive officers

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 6 wordings of this item as funds reported it.

82% Approved · of votes cast

FOR 82%AGAINST
FOR: 31,296,206AGAINST: 6,759,801
Details: description as filed, official tally, votes by 97 asset managers

Description as filed by funds: APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF OCUGEN, INC.'S NAMED EXECUTIVE OFFICERS.

OCUGEN INC.’s own tally for this item (“3. Approval, on an advisory basis, of the compensation of the Company's named executive officers”): 31,296,206 for, 6,759,801 against — passed, per its Form 8-K filed June 5, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The stockholders voted to approve, on an advisory basis, the compensation of the Company's named executive officers, as follows:”
Support: 82% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 29 asset managers voting on “APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF OCUGEN, INC.'S NAMED EXECUTIVE OFFICERS.” at OCUGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard1,128,7720 00For
Charles Schwab860,2440 00For
BlackRock345,8500 00For
Lincoln Financial219,4000 00For
Equitable211,8420 00For
Goldman Sachs187,1860 00For
Global X165,1460 00For
AIG/SunAmerica147,7870 00For
Northern Trust120,3040 00For
Pacific Life90,4620 00For
Voya78,6040 00For
Fidelity73,4520 00For
Bridge Builder Trust55,6850 00For
John Hancock53,5660 00For
SEI42,1000 00For
Columbia Threadneedle37,7020 00For
Calvert25,0680 00For
Brighthouse22,7650 00For
TIAA22,2710 00For
Nationwide18,2350 00For
ProShares15,4960 00For
State Street14,8690 00For
Brinker Capital Destinations Trust10,4170 00For
PENN SERIES FUNDS INC9,1000 00For
Guggenheim4,5360 00For

Fund voting reports, all 29 managers: 3,963,716 for. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 79 asset managers voting on “APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF OCUGEN, INC.'S NAMED EXECUTIVE OFFICERS.” at OCUGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
State Street3,046,4610 00For
BlackRock1,557,0920 00For
Northern Trust1,149,4570 00For
LASRY MARC1,056,3380 00For
MELLON INVESTMENTS Corp962,7110 00For
Charles Schwab860,2440 00For
Vanguard297,8020 00For
AllianceBernstein138,7300 00For
JPMorgan130,9230 00For
PNC BANK, NATIONAL ASSOCIATION124,2310 00For
Lanham O'Dell & Company, Inc.116,0000 00For
Citadel114,8080 00For
Invesco114,2110 00For
Rhumbline95,6220 00For
GEODE CAPITAL MANAGEMENT, LLC95,0820 00For
Nuveen82,2520 00For
Voya78,6040 00For
CAPTRUST FINANCIAL ADVISORS60,0000 00For
John Hancock53,8820 00For
Fidelity42,7220 00For
SEI42,1000 00For
OPPENHEIMER & CO INC36,1550 00For
Legal & General Investment Management America Inc032,760 00Against
MetLife Investment Management, LLC31,6320 00For
PRINCIPAL GLOBAL INVESTORS27,1650 00For

Institutional-manager reports, all 79 managers: 10,604,291 for, 36,725 against. Showing the 25 largest; every one is in the interactive database (link above).

8. Ratification of Independent Registered Public Accountant

Outcome not verifiedAUDIT-RELATEDReported outcome: Not verified

97% Majority: yes · of votes cast

FOR 97%
FOR: 101,459,299AGAINST: 3,030,767
Details: description as filed, official tally, votes by 29 asset managers

Description as filed by funds: Ratification of Appointment of PricewaterhouseCoopers LLP as Ocugen, Inc.'s Independent Registered Public Accounting Firm for 2025.

OCUGEN INC.’s own tally for this item (“2. Ratification of Independent Registered Public Accountant”): 101,459,299 for, 3,030,767 against, per its Form 8-K filed June 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 29 asset managers below reported 3,963,716 for.

FOR
FOR: 3,963,716
Largest asset managers voting on “Ratification of Appointment of PricewaterhouseCoopers LLP as Ocugen, Inc.'s Independent Registered Public Acco” at OCUGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard1,128,7720 00For
Charles Schwab860,2440 00For
BlackRock345,8500 00For
Lincoln Financial219,4000 00For
Equitable211,8420 00For
Goldman Sachs187,1860 00For
Global X165,1460 00For
AIG/SunAmerica147,7870 00For
Northern Trust120,3040 00For
Pacific Life90,4620 00For
Voya78,6040 00For
Fidelity73,4520 00For
Bridge Builder Trust55,6850 00For
John Hancock53,5660 00For
SEI42,1000 00For
Columbia Threadneedle37,7020 00For
Calvert25,0680 00For
Brighthouse22,7650 00For
TIAA22,2710 00For
Nationwide18,2350 00For
ProShares15,4960 00For
State Street14,8690 00For
Brinker Capital Destinations Trust10,4170 00For
PENN SERIES FUNDS INC9,1000 00For
Guggenheim4,5360 00For

Showing the 25 largest of 29 asset managers. All 29 are in the interactive database (link above).

Largest OCUGEN INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 292,031,295 shares outstanding at the time of that meeting.

Fund voting reports: top OCUGEN INC. shareholders by shares voted on “APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF OCUGEN, INC.'S NAMED EXECUTIVE OFFICERS.”, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 0.39%
2Charles Schwab 0.29%
3BlackRock 0.12%
4Lincoln Financial 0.08%
5Equitable 0.07%
6Goldman Sachs 0.06%
7Global X 0.06%
8AIG/SunAmerica 0.05%
9Northern Trust 0.04%
10Pacific Life 0.03%
Institutional-manager reports: top OCUGEN INC. shareholders by shares voted on “APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF OCUGEN, INC.'S NAMED EXECUTIVE OFFICERS.”, 2024-2025
#Asset manager % of shares outstanding
1State Street 1.04%
2BlackRock 0.53%
3Northern Trust 0.39%
4LASRY MARC 0.36%
5MELLON INVESTMENTS Corp 0.33%
6Charles Schwab 0.29%
7Vanguard 0.10%
8AllianceBernstein 0.05%
9JPMorgan 0.04%
10PNC BANK, NATIONAL ASSOCIATION 0.04%

Reported OCUGEN INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

OCUGEN INC. holdings and ownership disclosed for the 2024-2025 proxy season
Holder % outstanding Disclosure
JANUS HENDERSON GROUP PLC 6.85% 13G
BlackRock 6.70% 13F
Millennium Management LLC 5.85% 13G
Vanguard Group 5.71% 13F
Shankar Musunuri, Ph.D., MBA 2.80% DEF14A
Geode Capital 2.36% 13F
State Street 2.03% 13F
Renaissance Technologies 1.18% 13F
Northern Trust 0.80% 13F
Junge Zhang, Ph.D. 0.52% DEF14A

Percentages above are of 292,031,295 shares outstanding, as reported by OCUGEN INC. on its Form 10-Q dated May 2, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from OCUGEN INC.’s 10-Q dated May 2, 2025. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.

OCUGEN INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Cite this page

proxyvotesnow.com, “OCUGEN (OCGN) 2025 Annual Meeting: Vote Results & How Funds Voted”, https://proxyvotesnow.com/company/ocugen-inc/2025 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.